Thursday - May 1, 2025
DALLAS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, has been recognized with the 2025 Best in KLAS Scheduling: Nurse & Staff award for its industry leading nursing staff management technology, Smart Square®. Smart Square consistently ranked the highest among competitors every month in 2024, underscoring AMN Healthcare’s commitment to delivering innovation and excellence in workforce technology.
“AMN Healthcare is honored to receive this recognition from KLAS and I'd like to extend my heartfelt gratitude to our clients. The valuable feedback, suggestions and reviews from our clients were instrumental in helping Smart Square achieve this recognition. Smart Square’s success is a testament to our commitment to innovation and excellence in workforce technology. Our goal is to provide healthcare organizations with the tools they need to optimize their workforce and deliver the highest quality of care,” said Meredith Lapointe, Chief Business Officer at AMN Healthcare.
Smart Square’s top-tier performance in categories such as Culture, Operations and Value as mentioned in the 2025 Best in KLAS Awards report (Software and Services) highlights the ability to deliver comprehensive, reliable workforce solutions. The report attributed Smart Square’s success to its ability to provide precise staffing forecasts, enterprise-wide transparency, and ongoing guidance that drives continuous improvement.
“Healthcare customers continually share with KLAS how Smart Square empowers healthcare organizations with actionable insights and tools to enhance staff satisfaction, improve outcomes, and achieve significant cost savings,” said Niel Oscarson, RCM/Business Solutions Research Director at KLAS Research.
Smart Square’s ability to predict staffing needs with precision allows organizations to better align resources with demand, alleviating administrative burdens while optimizing workforce utilization. Enterprise-wide transparency ensures that stakeholders have access to critical insights, fostering improved collaboration.
For more information about AMN Healthcare and Smart Square, visit https://www.amnhealthcare.com/technology/workforce/scheduling/.
About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the United States. People are the heart of healthcare, and at the core of our mission is a commitment to ensure all may thrive. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies.
About KLAS
KLAS is a research and insights firm on a global mission to improve healthcare. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software and services to deliver timely reports and performance data that represent provider and payer voices and act as catalysts for improving vendor performance. The KLAS research team publishes reports covering the most pressing questions facing healthcare technology today, including emerging technology insights, that provide early insights on the future of healthcare technology solutions. KLAS also fosters measurement and collaboration between healthcare providers and payers and best practice adoption. Learn more at klasresearch.com.
Media Contact Corporate Communications AMN Healthcare AMN-PR@amnhealthcare.com | Investor Contact Randle Reece Senior Director, Investor Relations & Strategy AMN Healthcare (866) 861-3229 ir@amnhealthcare.com |
Last Trade: | US$20.42 |
Daily Change: | -0.01 -0.05 |
Daily Volume: | 1,022,430 |
Market Cap: | US$777.390M |
February 20, 2025 November 07, 2024 August 27, 2024 August 08, 2024 July 09, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load